5.44
0.91%
-0.05
アフターアワーズ:
5.44
Alector Inc (ALEC) 最新ニュース
Alector, Inc. (NASDAQ:ALEC) Short Interest Up 9.3% in April - Defense World
Defense World
Alector, Inc. (NASDAQ:ALEC) Short Interest Update - MarketBeat
MarketBeat
Alector Inc (ALEC) may enjoy gains as insiders got busy in the recent days – Knox Daily - Knox Daily
Knox Daily
Los Angeles Capital Management LLC Has $469000 Stake in Alector, Inc. (NASDAQ:ALEC) - Defense World
Defense World
HC Wainwright Trims Alector (NASDAQ:ALEC) Target Price to $35.00 - Defense World
Defense World
Are Options Traders Betting on a Big Move in Alector (ALEC) Stock? - Yahoo News UK
Yahoo News UK
Alector (ALEC) Stock Jumps 57.1%: Will It Continue to Soar? - Yahoo Singapore News
Yahoo Singapore News
Alector, Inc. (NASDAQ:ALEC) First-Quarter Results: Here's What Analysts Are Forecasting For This Year - Simply Wall St
Simply Wall St
Reflecting on Alector's (NASDAQ:ALEC) Share Price Returns Over The Last Year - Yahoo New Zealand News
Yahoo New Zealand News
Alector (ALEC) Surpasses Q2 Earnings and Revenue Estimates - Yahoo Singapore News
Yahoo Singapore News
Alector shares price target cut by $6, Buy rating held - Investing.com
Investing.com
Alector (NASDAQ:ALEC) Given New $35.00 Price Target at HC Wainwright - MarketBeat
MarketBeat
Alector's (ALEC) "Overweight" Rating Reiterated at Cantor Fitzgerald - MarketBeat
MarketBeat
Alector to Participate in Upcoming Healthcare Conferences - GlobeNewswire
GlobeNewswire
Alector to Participate in Upcoming Healthcare Conferences
GlobeNewswire Inc.
Alector: Q1 Earnings Snapshot - Houston Chronicle
Houston Chronicle
Alector Reports First Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire
GlobeNewswire
Alector (ALEC) Reports Q1 Loss, Tops Revenue Estimates - Zacks Investment Research
Zacks Investment Research
Taking a Closer Look At Alector Inc (ALEC) Following Its Recent Trade – Knox Daily - Knox Daily
Knox Daily
Alector, Inc. (NASDAQ:ALEC) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
MarketBeat
Alector (ALEC) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research
Alector Reports First Quarter 2024 Financial Results and Provides Business Update - The Bakersfield Californian
The Bakersfield Californian
Alector, Inc. (NASDAQ:ALEC) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
Defense World
Alector: Q1 Earnings Snapshot - Houston Chronicle
Houston Chronicle
Alector (ALEC) Up 7% on Finishing Enrolment in Alzheimer Study - Yahoo Movies Canada
Yahoo Movies Canada
Are Options Traders Betting on a Big Move in Alector (ALEC) Stock? - Yahoo Movies Canada
Yahoo Movies Canada
Alector (NASDAQ:ALEC) investors are sitting on a loss of 65% if they invested a year ago - Yahoo Movies Canada
Yahoo Movies Canada
Will Alector (ALEC) Report Negative Q1 Earnings? What You Should Know
Zacks Investment Research
Shareholders in Alector (NASDAQ:ALEC) have lost 75%, as stock drops 12% this past week - Simply Wall St
Simply Wall St
Alector Inc Announces Board Retirement and New Members - TipRanks.com - TipRanks
TipRanks
The Alector, Inc. (NASDAQ:ALEC) Full-Year Results Are Out And Analysts Have Published New Forecasts - Yahoo Finance
Yahoo Finance
Alector to Participate in Upcoming Healthcare Conferences
GlobeNewswire Inc.
Alector, Inc. (NASDAQ:ALEC) Q4 2023 Earnings Call Transcript - Yahoo Finance
Yahoo Finance
Alector Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update - Yahoo Finance
Yahoo Finance
Alector to Host Fourth Quarter and Full-Year 2023 Earnings Call
GlobeNewswire Inc.
Earnings Preview: Alector (ALEC) Q4 Earnings Expected to Decline
Zacks Investment Research
Alector to Host Fourth Quarter and Full-Year 2023 Earnings Call - GlobeNewswire
GlobeNewswire
Alector Announces First Patient Dosed in PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Patients with Early Alzheimer’s Disease
GlobeNewswire Inc.
Strength Seen in Alector (ALEC): Can Its 6.0% Jump Turn into More Strength?
Zacks Investment Research
Strength Seen in Alector (ALEC): Can Its 6.0% Jump Turn into More Strength? - Zacks Investment Research
Zacks Investment Research
FDA Grants Latozinemab Breakthrough Therapy Designation for Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN)
GlobeNewswire Inc.
FDA Grants Latozinemab Breakthrough Therapy Designation for Frontotemporal Dementia Due to a Progranulin Gene ... - Yahoo Finance
Yahoo Finance
Alector (ALEC) Upgraded to Strong Buy: Here's What You Should Know
Zacks Investment Research
Brain Disease Cures: 3 Neuroscience Stocks Targeting Revolutionary Breakthroughs - InvestorPlace
InvestorPlace
Alector Announces Closing of Public Offering
GlobeNewswire Inc.
Alector Announces Closing of Public Offering - Yahoo Finance
Yahoo Finance
Why Airspan Networks Shares Are Trading Higher By Over 380%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga
SolarEdge Technologies, Calavo Growers, Fisker And Other Big Stocks Moving Lower On Wednesday
Benzinga
Alector Announces Pricing of Public Offering of Common Stock
GlobeNewswire Inc.
Alector: Q4 2024 Data Release Could Provide Major Shift For Valuation (NASDAQ:ALEC) - Seeking Alpha
Seeking Alpha
大文字化:
|
ボリューム (24 時間):